BG Medicine (BGMD) Stock Price, News & Analysis

Company Overview

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 85,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BGMD Stock Analysis - Frequently Asked Questions

How were BG Medicine's earnings last quarter?

BG Medicine, Inc. (OTCMKTS:BGMD) announced its quarterly earnings results on Tuesday, November, 17th. The medical research company reported ($0.27) earnings per share for the quarter. The medical research company had revenue of $334 million for the quarter, compared to analysts' expectations of $695 million.

How do I buy shares of BG Medicine?

Shares of BGMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BG Medicine own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BG Medicine investors own include Aeterna Zentaris (AEZS), Glu Mobile (GLUU), Blue Ridge Mountain Resources (MHRCQ), ARCA biopharma (ABIO), Athersys (ATHX), Bristol-Myers Squibb (BMY) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

• Last Earnings: 11/17/2015
• Today: 1/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Diagnostic substances
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: OTCMKTS:BGMD
• Previous Symbol: NASDAQ:BGMD
• CUSIP: 08861T10
• CIK: 1407038
• Web: www.bg-medicine.com
• Phone: (508) 549-5710
• Fax: 781-895-1119
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.67